CareCloud, Inc.
NASDAQ•CCLD
CEO: Mr. Mahmud U. Haq
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Listing Date: 2014-07-23
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Contact Information
Market Cap
$122.95M
P/E (TTM)
11.0
47.3
Dividend Yield
--
52W High
$4.75
52W Low
$1.14
52W Range
Rank55Top 80.0%
2.6
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 2.6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q3 2025 Data
Revenue
$31.07M+8.83%
4-Quarter Trend
EPS
$0.04-197.09%
4-Quarter Trend
FCF
$6.50M-3.53%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Revenue Growth Strong Nine months revenue reached $86.1M, up 4% from $82.6M last year; Net Income $7.9M versus $4.6M.
Common Share Profitability Return Net income attributable to common shareholders swung to $2.37M profit from $4.47M loss for nine months period.
Major Acquisition Integration Closed Medsphere acquisition for $16.5M in August 2025, adding inpatient/ambulatory market access and technology assets.
Cash Position Improved Net cash provided by operating activities was $19.9M for nine months, increasing cash balance to $5.07M by period end.
Risk Factors
Acquisition Integration Challenges Ability to manage growth, including acquiring and effectively integrating Medsphere and other recent acquisitions poses risk.
Client Retention Uncertainty Risk exists regarding ability to retain current clients and maintain or grow existing revenue levels across all service lines.
Regulatory Compliance Burden Must consistently achieve and maintain compliance with myriad federal, state, foreign, local, payor, and industry requirements.
Cybersecurity and Data Risk Maintaining and protecting the privacy of confidential Company, client, and patient information presents ongoing operational risk.
Outlook
Focus on Profitability Growth Management expects efforts to enhance overall profitability, manage expenses, and grow revenue to continue supporting liquidity.
AI Technology Advancement Plans include incorporating AI faster and more successfully than competitors while protecting patient data and cybersecurity.
Preferred Stock Dividends Company plans to continue declaring monthly dividends after resuming payments in February 2025 following prior suspension.
Post-Period Acquisitions Planned Acquired MAP App in October 2025 for $468K cash plus assumed liabilities, expanding financial management tools.
Peer Comparison
Revenue (TTM)
$195.65M
$114.32M
ANIK$112.81M
Gross Margin (Latest Quarter)
RCEL81.3%
JYNT80.1%
71.8%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| RPID | $182.61M | -4.1 | -73.9% | 28.6% |
| JYNT | $152.64M | -193.0 | -3.7% | 3.0% |
| LNSR | $149.43M | -2.9 | 533.0% | 4.1% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
3.2%
Moderate Growth
4Q Net Income CAGR
-2.4%
Stable Profitability
Cash Flow Stability
100%
Strong Cash Flow
Research & Insights
Next earnings:Mar 12, 2026
EPS:$0.11
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Nov 6, 2025|Revenue: $31.07M+8.8%|EPS: $0.04-197.1%BeatForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Aug 5, 2025|Revenue: $27.38M-2.5%|EPS: $0.04-128.6%BeatForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 6, 2025|Revenue: $27.63M+6.4%|EPS: $-0.04-58.8%BeatForm 10-K/A - FY 2024
Period End: Dec 31, 2024|Filed: Apr 3, 2025|Revenue: $110.84M-5.3%|EPS: $-0.28+93.2%MissForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Mar 13, 2025|Refer to amended dataForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Nov 12, 2024|Revenue: $28.55M-2.5%|EPS: $-0.04-90.2%BeatForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 13, 2024|Revenue: $28.09M-4.3%|EPS: $-0.14+16.7%MissForm 10-Q - Q1 2024
Period End: Mar 31, 2024|Filed: May 14, 2024|Revenue: $25.96M-13.5%|EPS: $-0.10+273.1%Beat